Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today reported financial results for the second quarter ended June 30, 2026, and provided recent corporate...